Refine your search:     
Report No.
 - 
Search Results: Records 1-2 displayed on this page of 2
  • 1

Presentation/Publication Type

Initialising ...

Refine

Journal/Book Title

Initialising ...

Meeting title

Initialising ...

First Author

Initialising ...

Keyword

Initialising ...

Language

Initialising ...

Publication Year

Initialising ...

Held year of conference

Initialising ...

Save select records

Oral presentation

Crystal structure of human drug metabolizing enzyme CYP2C9 in complex with losartan determined by X-ray crystallography

Adachi, Motoyasu; Maekawa, Keiko*; Matsuzawa, Yumiko*; Saito, Yoshiro*; Kuroki, Ryota

no journal, , 

CYP2C9 belongs to cytochrome P450 and play an important role as human drug metabolizing enzyme. In this study, to elucidate molecular mechanism in drug metabolizing reaction by wild-type CYP2C9 and its SNP mutant *30, X-ray structures of their CYP2C9 molecules complexed with the drug were determined. CYP2C9 was truncated at N-terminal, expressed in E. coli, and homogeneously purified for crystallization. CYP2C9 Losartan complex was crystallized by co-crystallization. As a result of experiments using synchrotron radiation, diffraction data were obtained at 2.1${AA}$ resolution. The electron density maps of bound Losartan were observed in the both complexes.

Oral presentation

Purification of cytochrome P450 2C9.1, 2C9.3 and 2C9.30 expressed in ${it E. coli}$ and their activities toward arachidonic acid ${it in vitro}$

Maekawa, Keiko*; Matsuzawa, Yumiko*; Adachi, Motoyasu; Kuroki, Ryota; Saito, Yoshiro*

no journal, , 

2 (Records 1-2 displayed on this page)
  • 1